Grants - Revision history

Redaktor at 19:50, 22 October 2023

2023-10-22T19:50:35Z

← Older revision		Revision as of 21:50, 22 October 2023
Line 338:		Line 338:
	* <span class="pmbm">Grabowski F</span>, <span class="pmbm">Kochańczyk M</span>, <span class="pmbm">Lipniacki T</span>. '''The spread of SARS-CoV-2 variant Omicron with the doubling time of 2.0–3.3 days can be explained by immune evasion''', ''Viruses'' <u>14</u>(2):294 (2022) [https://doi.org/10.3390/v14020294 CrossRef] [https://dx.doi.org/10.1101/2021.12.08.21267494 medRxiv] \| [https://www.mdpi.com/1999-4915/14/2/294/pdf PDF] [https://susy.mdpi.com/user/review/displayFile/23340271/tDGR6nk0?file=author-coverletter&report=16624478 Korespondencja]<br/>[[File:article_omicron_1.png\|x175px\|link=https://doi.org/10.3390/v14020294]]<br/><br/>		* <span class="pmbm">Grabowski F</span>, <span class="pmbm">Kochańczyk M</span>, <span class="pmbm">Lipniacki T</span>. '''The spread of SARS-CoV-2 variant Omicron with the doubling time of 2.0–3.3 days can be explained by immune evasion''', ''Viruses'' <u>14</u>(2):294 (2022) [https://doi.org/10.3390/v14020294 CrossRef] [https://dx.doi.org/10.1101/2021.12.08.21267494 medRxiv] \| [https://www.mdpi.com/1999-4915/14/2/294/pdf PDF] [https://susy.mdpi.com/user/review/displayFile/23340271/tDGR6nk0?file=author-coverletter&report=16624478 Korespondencja]<br/>[[File:article_omicron_1.png\|x175px\|link=https://doi.org/10.3390/v14020294]]<br/><br/>
	* <span class="nopmbm">Mines RC</span>, <span class="pmbm">Lipniacki T</span>, <span class="nopmbm">Shen X</span>. '''Slow nucleosome dynamics set the transcriptional speed limit and induce RNA polymerase II traffic jams and bursts''', ''PLOS Comput Biol'' <u>18</u>(2):e1009811 (2022) [https://doi.org/10.1371/journal.pcbi.1009811 CrossRef]<br/>[[File:article_nucleodyn_1.png\|175px\|link=https://doi.org/10.1371/journal.pcbi.1009811]]<br/><br/>		* <span class="nopmbm">Mines RC</span>, <span class="pmbm">Lipniacki T</span>, <span class="nopmbm">Shen X</span>. '''Slow nucleosome dynamics set the transcriptional speed limit and induce RNA polymerase II traffic jams and bursts''', ''PLOS Comput Biol'' <u>18</u>(2):e1009811 (2022) [https://doi.org/10.1371/journal.pcbi.1009811 CrossRef]<br/>[[File:article_nucleodyn_1.png\|175px\|link=https://doi.org/10.1371/journal.pcbi.1009811]]<br/><br/>
	* <span class="pmbm">Korwek Z</span>, <span class="pmbm">Czerkies M</span>, <span class="pmbm">Jaruszewicz-Błońska J</span>, <span class="pmbm">Prus W</span>, <span class="pmbm">Kosiuk I</span>, <span class="pmbm">Kochańczyk M</span>, <span class="pmbm">Lipniacki T</span>. '''Non-self RNA rewires IFNβ signaling: A mathematical model of the innate immune response''' (~~submitted~~) [https://doi.org/10.1101/2022.01.30.478391 bioRxiv]<br/>[[File:article_non-self_1.png\|300px\|link=https://doi.org/10.1101/2022.01.30.478391]]<br/>[[File:article_non-self_2.png\|300px\|link=https://doi.org/10.1101/2022.01.30.478391]]<br/><br/>		* <span class="pmbm">Korwek Z</span>, <span class="pmbm">Czerkies M</span>, <span class="pmbm">Jaruszewicz-Błońska J</span>, <span class="pmbm">Prus W</span>, <span class="pmbm">Kosiuk I</span>, <span class="pmbm">Kochańczyk M</span>, <span class="pmbm">Lipniacki T</span>. '''Non-self RNA rewires IFNβ signaling: A mathematical model of the innate immune response''' (przyjęte do ''Sci Signal'') [https://doi.org/10.1101/2022.01.30.478391 bioRxiv]<br/>[[File:article_non-self_1.png\|300px\|link=https://doi.org/10.1101/2022.01.30.478391]]<br/>[[File:article_non-self_2.png\|300px\|link=https://doi.org/10.1101/2022.01.30.478391]]<br/><br/>
	====Inne====		====Inne====
	* Wykład: ''SARS-CoV-2 super-spreaders and super-spreading Variant of Concern 202012/01'', Uniwersytet Warszawski, Wydział Fizyki (Tomasz Lipniacki)		* Wykład: ''SARS-CoV-2 super-spreaders and super-spreading Variant of Concern 202012/01'', Uniwersytet Warszawski, Wydział Fizyki (Tomasz Lipniacki)

Redaktor at 19:48, 22 October 2023

2023-10-22T19:48:51Z

← Older revision		Revision as of 21:48, 22 October 2023
Line 223:		Line 223:
	===Research===		===Research===
	====Scientific publications====		====Scientific publications====
			* <span class="pmbm">Grabowski F</span>, <span class="pmbm">Kochańczyk M</span>, <span class="pmbm">Korwek Z</span>, <span class="pmbm">Czerkies M</span>, <span class="pmbm">Prus W</span>, <span class="pmbm">Lipniacki T</span>. '''Antagonism between viral infection and innate immunity at the single-cell level''', ''PLOS Pathog'' <u>19</u>(9):e1011597 (2023) [https://pubmed.ncbi.nlm.nih.gov/37669278 PubMed] [https://doi.org/10.1371/journal.ppat.1011597 CrossRef] \| [https://doi.org/10.1101/2022.11.18.517110 bioRxiv] [https://github.com/grfrederic/visavis Code] [https://doi.org/10.5281/zenodo.7428925 Data]<br/><br/>
			* <span class="pmbm">Kurniawan T</span>, <span class="nopmbm">Sahebdivani M</span>, <span class="pmbm">Zaremba D</span>, <span class="pmbm">Blonski S</span>, <span class="nopmbm">Garstecki P</span>, <span class="nopmbm">van Steijn V</span>, <span class="pmbm">Korczyk PM</span>. '''Formation of droplets in microfluidic cross-junctions at small capillary numbers: Breakdown of the classical squeezing regime''', ''Chem Eng J'' <u>474</u>:145601 (2023) [https://doi.org/10.1016/j.cej.2023.145601 CrossRef]<br/><br/>
			* <span class="pmbm">Grabowski F</span>, <span class="pmbm">Nałęcz-Jawecki P</span>, <span class="pmbm">Lipniacki T</span>. '''Predictive power of non-identifiable models''', ''Sci Rep'' <u>13</u>:11143 (2023) [https://doi.org/10.1038/s41598-023-37939-8 CrossRef] [https://doi.org/10.1101/2023.04.07.536025 bioRxiv] [https://github.com/grfrederic/identifiability Code]<br/><br/>
	* <span class="nopmbm">Sønstevold L</span>, <span class="pmbm">Czerkies M</span>, <span class="nopmbm">Escobedo-Cousin E</span>, <span class="pmbm">Blonski S</span>, <span class="nopmbm">Vereshchagina E</span>. '''Application of polymethylpentene, an oxygen permeable thermoplastic, for long-term on-a-chip cell culture and organ-on-a-chip devices''', ''Micromachines'' <u>14</u>(3):532 (2023) [https://dx.doi.org/10.3390/mi14030532 CrossRef]<br/><br/>		* <span class="nopmbm">Sønstevold L</span>, <span class="pmbm">Czerkies M</span>, <span class="nopmbm">Escobedo-Cousin E</span>, <span class="pmbm">Blonski S</span>, <span class="nopmbm">Vereshchagina E</span>. '''Application of polymethylpentene, an oxygen permeable thermoplastic, for long-term on-a-chip cell culture and organ-on-a-chip devices''', ''Micromachines'' <u>14</u>(3):532 (2023) [https://dx.doi.org/10.3390/mi14030532 CrossRef]<br/><br/>
	* <span class="author">Czerkies M</span>, <span class="author">Kochańczyk M</span>, <span class="author">Korwek Z</span>, <span class="author">Prus W</span>, <span class="author">Lipniacki T</span>. '''Respiratory syncytial virus protects bystander cells against influenza A virus infection by triggering secretion of type I and type III interferons''', ''J Virol'' (2022) <u>96</u>:22 e01341-22 [https://doi.org/10.1128/jvi.01341-22 CrossRef] [https://doi.org/10.1101/2021.10.11.463877 bioRxiv]<br/>[[File:article_RSV_IAV_crossprotection.png\|450px\|link=https://doi.org/10.1128/jvi.01341-22]]<br/><br/>		* <span class="author">Czerkies M</span>, <span class="author">Kochańczyk M</span>, <span class="author">Korwek Z</span>, <span class="author">Prus W</span>, <span class="author">Lipniacki T</span>. '''Respiratory syncytial virus protects bystander cells against influenza A virus infection by triggering secretion of type I and type III interferons''', ''J Virol'' (2022) <u>96</u>:22 e01341-22 [https://doi.org/10.1128/jvi.01341-22 CrossRef] [https://doi.org/10.1101/2021.10.11.463877 bioRxiv]<br/>[[File:article_RSV_IAV_crossprotection.png\|450px\|link=https://doi.org/10.1128/jvi.01341-22]]<br/><br/>
Line 228:		Line 231:
	* <span class="pmbm">Grabowski F</span>, <span class="pmbm">Kochańczyk M</span>, <span class="pmbm">Lipniacki T</span>. '''The spread of SARS-CoV-2 variant Omicron with the doubling time of 2.0–3.3 days can be explained by immune evasion''', ''Viruses'' <u>14</u>(2):294 (2022) [https://doi.org/10.3390/v14020294 CrossRef] [https://dx.doi.org/10.1101/2021.12.08.21267494 medRxiv] \| [https://www.mdpi.com/1999-4915/14/2/294/pdf PDF] [https://susy.mdpi.com/user/review/displayFile/23340271/tDGR6nk0?file=author-coverletter&report=16624478 Correspondence]<br/>[[File:article_omicron_1.png\|x175px\|link=https://doi.org/10.3390/v14020294]]<br/><br/>		* <span class="pmbm">Grabowski F</span>, <span class="pmbm">Kochańczyk M</span>, <span class="pmbm">Lipniacki T</span>. '''The spread of SARS-CoV-2 variant Omicron with the doubling time of 2.0–3.3 days can be explained by immune evasion''', ''Viruses'' <u>14</u>(2):294 (2022) [https://doi.org/10.3390/v14020294 CrossRef] [https://dx.doi.org/10.1101/2021.12.08.21267494 medRxiv] \| [https://www.mdpi.com/1999-4915/14/2/294/pdf PDF] [https://susy.mdpi.com/user/review/displayFile/23340271/tDGR6nk0?file=author-coverletter&report=16624478 Correspondence]<br/>[[File:article_omicron_1.png\|x175px\|link=https://doi.org/10.3390/v14020294]]<br/><br/>
	* <span class="nopmbm">Mines RC</span>, <span class="pmbm">Lipniacki T</span>, <span class="nopmbm">Shen X</span>. '''Slow nucleosome dynamics set the transcriptional speed limit and induce RNA polymerase II traffic jams and bursts''', ''PLOS Comput Biol'' <u>18</u>(2):e1009811 (2022) [https://doi.org/10.1371/journal.pcbi.1009811 CrossRef]<br/>[[File:article_nucleodyn_1.png\|175px\|link=https://doi.org/10.1371/journal.pcbi.1009811]]<br/><br/>		* <span class="nopmbm">Mines RC</span>, <span class="pmbm">Lipniacki T</span>, <span class="nopmbm">Shen X</span>. '''Slow nucleosome dynamics set the transcriptional speed limit and induce RNA polymerase II traffic jams and bursts''', ''PLOS Comput Biol'' <u>18</u>(2):e1009811 (2022) [https://doi.org/10.1371/journal.pcbi.1009811 CrossRef]<br/>[[File:article_nucleodyn_1.png\|175px\|link=https://doi.org/10.1371/journal.pcbi.1009811]]<br/><br/>
	* <span class="pmbm">Korwek Z</span>, <span class="pmbm">Czerkies M</span>, <span class="pmbm">Jaruszewicz-Błońska J</span>, <span class="pmbm">Prus W</span>, <span class="pmbm">Kosiuk I</span>, <span class="pmbm">Kochańczyk M</span>, <span class="pmbm">Lipniacki T</span>. '''Non-self RNA rewires IFNβ signaling: A mathematical model of the innate immune response''' (~~submitted~~) [https://doi.org/10.1101/2022.01.30.478391 bioRxiv]<br/>[[File:article_non-self_1.png\|300px\|link=https://doi.org/10.1101/2022.01.30.478391]]<br/>[[File:article_non-self_2.png\|300px\|link=https://doi.org/10.1101/2022.01.30.478391]]<br/><br/>		* <span class="pmbm">Korwek Z</span>, <span class="pmbm">Czerkies M</span>, <span class="pmbm">Jaruszewicz-Błońska J</span>, <span class="pmbm">Prus W</span>, <span class="pmbm">Kosiuk I</span>, <span class="pmbm">Kochańczyk M</span>, <span class="pmbm">Lipniacki T</span>. '''Non-self RNA rewires IFNβ signaling: A mathematical model of the innate immune response''' (accepted at ''Sci Signal'') [https://doi.org/10.1101/2022.01.30.478391 bioRxiv]<br/>[[File:article_non-self_1.png\|300px\|link=https://doi.org/10.1101/2022.01.30.478391]]<br/>[[File:article_non-self_2.png\|300px\|link=https://doi.org/10.1101/2022.01.30.478391]]<br/><br/>
	====Other====		====Other====
	* Lecture: ''SARS-CoV-2 super-spreaders and super-spreading Variant of Concern 202012/01'', University of Warsaw, Faculty of Physics (Tomasz Lipniacki)		* Lecture: ''SARS-CoV-2 super-spreaders and super-spreading Variant of Concern 202012/01'', University of Warsaw, Faculty of Physics (Tomasz Lipniacki)
Line 327:		Line 330:
	===Wyniki===		===Wyniki===
	====Publikacje====		====Publikacje====
			* <span class="pmbm">Grabowski F</span>, <span class="pmbm">Kochańczyk M</span>, <span class="pmbm">Korwek Z</span>, <span class="pmbm">Czerkies M</span>, <span class="pmbm">Prus W</span>, <span class="pmbm">Lipniacki T</span>. '''Antagonism between viral infection and innate immunity at the single-cell level''', ''PLOS Pathog'' <u>19</u>(9):e1011597 (2023) [https://pubmed.ncbi.nlm.nih.gov/37669278 PubMed] [https://doi.org/10.1371/journal.ppat.1011597 CrossRef] \| [https://doi.org/10.1101/2022.11.18.517110 bioRxiv] [https://github.com/grfrederic/visavis Code] [https://doi.org/10.5281/zenodo.7428925 Data]<br/><br/>
			* <span class="pmbm">Kurniawan T</span>, <span class="nopmbm">Sahebdivani M</span>, <span class="pmbm">Zaremba D</span>, <span class="pmbm">Blonski S</span>, <span class="nopmbm">Garstecki P</span>, <span class="nopmbm">van Steijn V</span>, <span class="pmbm">Korczyk PM</span>. '''Formation of droplets in microfluidic cross-junctions at small capillary numbers: Breakdown of the classical squeezing regime''', ''Chem Eng J'' <u>474</u>:145601 (2023) [https://doi.org/10.1016/j.cej.2023.145601 CrossRef]<br/><br/>
			* <span class="pmbm">Grabowski F</span>, <span class="pmbm">Nałęcz-Jawecki P</span>, <span class="pmbm">Lipniacki T</span>. '''Predictive power of non-identifiable models''', ''Sci Rep'' <u>13</u>:11143 (2023) [https://doi.org/10.1038/s41598-023-37939-8 CrossRef] [https://doi.org/10.1101/2023.04.07.536025 bioRxiv] [https://github.com/grfrederic/identifiability Code]<br/><br/>
	* <span class="nopmbm">Sønstevold L</span>, <span class="pmbm">Czerkies M</span>, <span class="nopmbm">Escobedo-Cousin E</span>, <span class="pmbm">Blonski S</span>, <span class="nopmbm">Vereshchagina E</span>. '''Application of polymethylpentene, an oxygen permeable thermoplastic, for long-term on-a-chip cell culture and organ-on-a-chip devices''', ''Micromachines'' <u>14</u>(3):532 (2023) [https://dx.doi.org/10.3390/mi14030532 CrossRef]<br/><br/>		* <span class="nopmbm">Sønstevold L</span>, <span class="pmbm">Czerkies M</span>, <span class="nopmbm">Escobedo-Cousin E</span>, <span class="pmbm">Blonski S</span>, <span class="nopmbm">Vereshchagina E</span>. '''Application of polymethylpentene, an oxygen permeable thermoplastic, for long-term on-a-chip cell culture and organ-on-a-chip devices''', ''Micromachines'' <u>14</u>(3):532 (2023) [https://dx.doi.org/10.3390/mi14030532 CrossRef]<br/><br/>
	* <span class="author">Czerkies M</span>, <span class="author">Kochańczyk M</span>, <span class="author">Korwek Z</span>, <span class="author">Prus W</span>, <span class="author">Lipniacki T</span>. '''Respiratory syncytial virus protects bystander cells against influenza A virus infection by triggering secretion of type I and type III interferons''', ''J Virol'' (2022) <u>96</u>:22 e01341-22 [https://doi.org/10.1128/jvi.01341-22 CrossRef] [https://doi.org/10.1101/2021.10.11.463877 bioRxiv]<br/>[[File:article_RSV_IAV_crossprotection.png\|450px\|link=https://doi.org/10.1128/jvi.01341-22]]<br/><br/>		* <span class="author">Czerkies M</span>, <span class="author">Kochańczyk M</span>, <span class="author">Korwek Z</span>, <span class="author">Prus W</span>, <span class="author">Lipniacki T</span>. '''Respiratory syncytial virus protects bystander cells against influenza A virus infection by triggering secretion of type I and type III interferons''', ''J Virol'' (2022) <u>96</u>:22 e01341-22 [https://doi.org/10.1128/jvi.01341-22 CrossRef] [https://doi.org/10.1101/2021.10.11.463877 bioRxiv]<br/>[[File:article_RSV_IAV_crossprotection.png\|450px\|link=https://doi.org/10.1128/jvi.01341-22]]<br/><br/>

Redaktor at 11:42, 4 October 2023

2023-10-04T11:42:35Z

← Older revision		Revision as of 13:42, 4 October 2023
Line 8:		Line 8:
	<div class="tab-content">		<div class="tab-content">
	<div id="CurrentGrants" class="tab-pane fade show active" role="tabpanel">		<div id="CurrentGrants" class="tab-pane fade show active" role="tabpanel">

			*''Combinatorial targeting of non-genetic sources of cell-to-cell heterogeneity to overcome fractional killing of cancer cells''.<br/>National Science Centre (NCN): Opus, 2022–2025.<br/>PI: Jarosław Walczak

	*''Cell-to-cell heterogeneity of cross-wired cytokine signaling: filling the gaps between molecular origins and translational implications''.<br/>National Science Centre (NCN): Opus, 2021–2025.<br/>PI: Michał Komorowski		*''Cell-to-cell heterogeneity of cross-wired cytokine signaling: filling the gaps between molecular origins and translational implications''.<br/>National Science Centre (NCN): Opus, 2021–2025.<br/>PI: Michał Komorowski

Redaktor at 11:41, 4 October 2023

2023-10-04T11:41:18Z

← Older revision		Revision as of 13:41, 4 October 2023
Line 8:		Line 8:
	<div class="tab-content">		<div class="tab-content">
	<div id="CurrentGrants" class="tab-pane fade show active" role="tabpanel">		<div id="CurrentGrants" class="tab-pane fade show active" role="tabpanel">

			*''Cell-to-cell heterogeneity of cross-wired cytokine signaling: filling the gaps between molecular origins and translational implications''.<br/>National Science Centre (NCN): Opus, 2021–2025.<br/>PI: Michał Komorowski

	*''Interaction of natural killer cells with an infected cancer cell population: microfluidics-based experiments and single-cell-level mathematical modeling''.<br/>National Science Centre (NCN): '''Grieg''' (Norwegian Financial Mechanism), 2020–2023.<br/>PI: Tomasz Lipniacki		*''Interaction of natural killer cells with an infected cancer cell population: microfluidics-based experiments and single-cell-level mathematical modeling''.<br/>National Science Centre (NCN): '''Grieg''' (Norwegian Financial Mechanism), 2020–2023.<br/>PI: Tomasz Lipniacki

Redaktor at 15:07, 27 September 2023

2023-09-27T15:07:54Z

← Older revision		Revision as of 17:07, 27 September 2023
Line 14:		Line 14:

	*''Sprayable multifunctional nanofibrous hydrogels for polytherapeutic wound healing treatments''.<br/>National Centre for Research and Development (NCBiR): 2nd Polish–Chinese/Chinese–Polish Joint Research Call, 2021–2024.<br/>PI: Filippo Pierini		*''Sprayable multifunctional nanofibrous hydrogels for polytherapeutic wound healing treatments''.<br/>National Centre for Research and Development (NCBiR): 2nd Polish–Chinese/Chinese–Polish Joint Research Call, 2021–2024.<br/>PI: Filippo Pierini

	*''Electrospun conducting hydrogel nanomaterials for neural tissue engineering''.<br/>Foundation for Polish Science ('''FNP'''): '''First Team''', 2019–2022.<br/>PI: Filippo Pierini

	</div> <!-- CurrentGrants -->		</div> <!-- CurrentGrants -->
	<div id="PastGrants" class="tab-pane fade" role="tabpanel">		<div id="PastGrants" class="tab-pane fade" role="tabpanel">

	*''~~Deciphering biochemical signalling to inform more efficient therapeutic strategies~~''.<br/>Foundation for Polish Science ('''FNP'''): '''First Team''', ~~2018–2021~~<br/>PI: ~~Michał Komorowski~~		*''Electrospun conducting hydrogel nanomaterials for neural tissue engineering''.<br/>Foundation for Polish Science ('''FNP'''): '''First Team''', 2019–2022.<br/>PI: Filippo Pierini

	*''Coordination of innate immune response in infected cell population: experiment and mathematical modeling''.<br/>National Science Centre (NCN): Opus 15, 2019–2022.<br/>PI: Tomasz Lipniacki		*''Coordination of innate immune response in infected cell population: experiment and mathematical modeling''.<br/>National Science Centre (NCN): Opus 15, 2019–2022.<br/>PI: Tomasz Lipniacki

			*''Deciphering biochemical signalling to inform more efficient therapeutic strategies''.<br/>Foundation for Polish Science ('''FNP'''): '''First Team''', 2018–2021<br/>PI: Michał Komorowski

	*''Development of novel methods for measuring viscosity and interfacial tension of liquids using microfluidic devices''.<br/>National Science Centre (NCN): Preludium 15, 2019–2022.<br/>PI: Damian Zaremba		*''Development of novel methods for measuring viscosity and interfacial tension of liquids using microfluidic devices''.<br/>National Science Centre (NCN): Preludium 15, 2019–2022.<br/>PI: Damian Zaremba

Redaktor at 21:20, 28 August 2023

2023-08-28T21:20:06Z

← Older revision		Revision as of 23:20, 28 August 2023
Line 219:		Line 219:
	===Research===		===Research===
	====Scientific publications====		====Scientific publications====
	* <span class="nopmbm">Sønstevold L</span>, <span class="pmbm">Czerkies M</span>, <span class="nopmbm">Escobedo-Cousin E</span>, <span class="pmbm">Blonski S</span>, <span class="nopmbm">Vereshchagina E</span>. ''Micromachines'' <u>14</u>(3):532 (2023) [https://dx.doi.org/10.3390/mi14030532 CrossRef]<br/><br/>		* <span class="nopmbm">Sønstevold L</span>, <span class="pmbm">Czerkies M</span>, <span class="nopmbm">Escobedo-Cousin E</span>, <span class="pmbm">Blonski S</span>, <span class="nopmbm">Vereshchagina E</span>. '''Application of polymethylpentene, an oxygen permeable thermoplastic, for long-term on-a-chip cell culture and organ-on-a-chip devices''', ''Micromachines'' <u>14</u>(3):532 (2023) [https://dx.doi.org/10.3390/mi14030532 CrossRef]<br/><br/>
	* <span class="author">Czerkies M</span>, <span class="author">Kochańczyk M</span>, <span class="author">Korwek Z</span>, <span class="author">Prus W</span>, <span class="author">Lipniacki T</span>. '''Respiratory syncytial virus protects bystander cells against influenza A virus infection by triggering secretion of type I and type III interferons''', ''J Virol'' (2022) <u>96</u>:22 e01341-22 [https://doi.org/10.1128/jvi.01341-22 CrossRef] [https://doi.org/10.1101/2021.10.11.463877 bioRxiv]<br/>[[File:article_RSV_IAV_crossprotection.png\|450px\|link=https://doi.org/10.1128/jvi.01341-22]]<br/><br/>		* <span class="author">Czerkies M</span>, <span class="author">Kochańczyk M</span>, <span class="author">Korwek Z</span>, <span class="author">Prus W</span>, <span class="author">Lipniacki T</span>. '''Respiratory syncytial virus protects bystander cells against influenza A virus infection by triggering secretion of type I and type III interferons''', ''J Virol'' (2022) <u>96</u>:22 e01341-22 [https://doi.org/10.1128/jvi.01341-22 CrossRef] [https://doi.org/10.1101/2021.10.11.463877 bioRxiv]<br/>[[File:article_RSV_IAV_crossprotection.png\|450px\|link=https://doi.org/10.1128/jvi.01341-22]]<br/><br/>
	* <span class="pmbm">Grabowski F</span>, <span class="nopmbm">Preibisch G</span>, <span class="nopmbm">Giziński S</span>, <span class="pmbm">Kochańczyk M</span>, <span class="pmbm">Lipniacki T</span>. '''SARS-CoV-2 Variant of Concern 202012/01 has about twofold replicative advantage and acquires concerning mutations''', ''Viruses'' <u>13</u>(3):392 (2021) [https://doi.org/10.3390/v13030392 CrossRef] [https://doi.org/10.1101/2020.12.28.20248906 medRxiv] \| [https://www.mdpi.com/1999-4915/13/3/392/pdf PDF]<br/>[[File:article_alpha_1.png\|x175px\|link=https://doi.org/10.3390/v13030392]] [[File:article_alpha_2.png\|x175px\|link=https://doi.org/10.3390/v13030392]]<br/><br/>		* <span class="pmbm">Grabowski F</span>, <span class="nopmbm">Preibisch G</span>, <span class="nopmbm">Giziński S</span>, <span class="pmbm">Kochańczyk M</span>, <span class="pmbm">Lipniacki T</span>. '''SARS-CoV-2 Variant of Concern 202012/01 has about twofold replicative advantage and acquires concerning mutations''', ''Viruses'' <u>13</u>(3):392 (2021) [https://doi.org/10.3390/v13030392 CrossRef] [https://doi.org/10.1101/2020.12.28.20248906 medRxiv] \| [https://www.mdpi.com/1999-4915/13/3/392/pdf PDF]<br/>[[File:article_alpha_1.png\|x175px\|link=https://doi.org/10.3390/v13030392]] [[File:article_alpha_2.png\|x175px\|link=https://doi.org/10.3390/v13030392]]<br/><br/>
Line 323:		Line 323:
	===Wyniki===		===Wyniki===
	====Publikacje====		====Publikacje====
	* <span class="nopmbm">Sønstevold L</span>, <span class="pmbm">Czerkies M</span>, <span class="nopmbm">Escobedo-Cousin E</span>, <span class="pmbm">Blonski S</span>, <span class="nopmbm">Vereshchagina E</span>. ''Micromachines'' <u>14</u>(3):532 (2023) [https://dx.doi.org/10.3390/mi14030532 CrossRef]<br/><br/>		* <span class="nopmbm">Sønstevold L</span>, <span class="pmbm">Czerkies M</span>, <span class="nopmbm">Escobedo-Cousin E</span>, <span class="pmbm">Blonski S</span>, <span class="nopmbm">Vereshchagina E</span>. '''Application of polymethylpentene, an oxygen permeable thermoplastic, for long-term on-a-chip cell culture and organ-on-a-chip devices''', ''Micromachines'' <u>14</u>(3):532 (2023) [https://dx.doi.org/10.3390/mi14030532 CrossRef]<br/><br/>
	* <span class="author">Czerkies M</span>, <span class="author">Kochańczyk M</span>, <span class="author">Korwek Z</span>, <span class="author">Prus W</span>, <span class="author">Lipniacki T</span>. '''Respiratory syncytial virus protects bystander cells against influenza A virus infection by triggering secretion of type I and type III interferons''', ''J Virol'' (2022) <u>96</u>:22 e01341-22 [https://doi.org/10.1128/jvi.01341-22 CrossRef] [https://doi.org/10.1101/2021.10.11.463877 bioRxiv]<br/>[[File:article_RSV_IAV_crossprotection.png\|450px\|link=https://doi.org/10.1128/jvi.01341-22]]<br/><br/>		* <span class="author">Czerkies M</span>, <span class="author">Kochańczyk M</span>, <span class="author">Korwek Z</span>, <span class="author">Prus W</span>, <span class="author">Lipniacki T</span>. '''Respiratory syncytial virus protects bystander cells against influenza A virus infection by triggering secretion of type I and type III interferons''', ''J Virol'' (2022) <u>96</u>:22 e01341-22 [https://doi.org/10.1128/jvi.01341-22 CrossRef] [https://doi.org/10.1101/2021.10.11.463877 bioRxiv]<br/>[[File:article_RSV_IAV_crossprotection.png\|450px\|link=https://doi.org/10.1128/jvi.01341-22]]<br/><br/>
	* <span class="pmbm">Grabowski F</span>, <span class="nopmbm">Preibisch G</span>, <span class="nopmbm">Giziński S</span>, <span class="pmbm">Kochańczyk M</span>, <span class="pmbm">Lipniacki T</span>. '''SARS-CoV-2 Variant of Concern 202012/01 has about twofold replicative advantage and acquires concerning mutations''', ''Viruses'' <u>13</u>(3):392 (2021) [https://doi.org/10.3390/v13030392 CrossRef] [https://doi.org/10.1101/2020.12.28.20248906 medRxiv] \| [https://www.mdpi.com/1999-4915/13/3/392/pdf PDF]<br/>[[File:article_alpha_1.png\|x175px\|link=https://doi.org/10.3390/v13030392]] [[File:article_alpha_2.png\|x175px\|link=https://doi.org/10.3390/v13030392]]<br/><br/>		* <span class="pmbm">Grabowski F</span>, <span class="nopmbm">Preibisch G</span>, <span class="nopmbm">Giziński S</span>, <span class="pmbm">Kochańczyk M</span>, <span class="pmbm">Lipniacki T</span>. '''SARS-CoV-2 Variant of Concern 202012/01 has about twofold replicative advantage and acquires concerning mutations''', ''Viruses'' <u>13</u>(3):392 (2021) [https://doi.org/10.3390/v13030392 CrossRef] [https://doi.org/10.1101/2020.12.28.20248906 medRxiv] \| [https://www.mdpi.com/1999-4915/13/3/392/pdf PDF]<br/>[[File:article_alpha_1.png\|x175px\|link=https://doi.org/10.3390/v13030392]] [[File:article_alpha_2.png\|x175px\|link=https://doi.org/10.3390/v13030392]]<br/><br/>

Redaktor at 21:14, 28 August 2023

2023-08-28T21:14:54Z

← Older revision		Revision as of 23:14, 28 August 2023
Line 219:		Line 219:
	===Research===		===Research===
	====Scientific publications====		====Scientific publications====
			* <span class="nopmbm">Sønstevold L</span>, <span class="pmbm">Czerkies M</span>, <span class="nopmbm">Escobedo-Cousin E</span>, <span class="pmbm">Blonski S</span>, <span class="nopmbm">Vereshchagina E</span>. ''Micromachines'' <u>14</u>(3):532 (2023) [https://dx.doi.org/10.3390/mi14030532 CrossRef]<br/><br/>
	* <span class="author">Czerkies M</span>, <span class="author">Kochańczyk M</span>, <span class="author">Korwek Z</span>, <span class="author">Prus W</span>, <span class="author">Lipniacki T</span>. '''Respiratory syncytial virus protects bystander cells against influenza A virus infection by triggering secretion of type I and type III interferons''', ''J Virol'' (2022) <u>96</u>:22 e01341-22 [https://doi.org/10.1128/jvi.01341-22 CrossRef] [https://doi.org/10.1101/2021.10.11.463877 bioRxiv]<br/>[[File:article_RSV_IAV_crossprotection.png\|450px\|link=https://doi.org/10.1128/jvi.01341-22]]<br/><br/>		* <span class="author">Czerkies M</span>, <span class="author">Kochańczyk M</span>, <span class="author">Korwek Z</span>, <span class="author">Prus W</span>, <span class="author">Lipniacki T</span>. '''Respiratory syncytial virus protects bystander cells against influenza A virus infection by triggering secretion of type I and type III interferons''', ''J Virol'' (2022) <u>96</u>:22 e01341-22 [https://doi.org/10.1128/jvi.01341-22 CrossRef] [https://doi.org/10.1101/2021.10.11.463877 bioRxiv]<br/>[[File:article_RSV_IAV_crossprotection.png\|450px\|link=https://doi.org/10.1128/jvi.01341-22]]<br/><br/>
	* <span class="pmbm">Grabowski F</span>, <span class="nopmbm">Preibisch G</span>, <span class="nopmbm">Giziński S</span>, <span class="pmbm">Kochańczyk M</span>, <span class="pmbm">Lipniacki T</span>. '''SARS-CoV-2 Variant of Concern 202012/01 has about twofold replicative advantage and acquires concerning mutations''', ''Viruses'' <u>13</u>(3):392 (2021) [https://doi.org/10.3390/v13030392 CrossRef] [https://doi.org/10.1101/2020.12.28.20248906 medRxiv] \| [https://www.mdpi.com/1999-4915/13/3/392/pdf PDF]<br/>[[File:article_alpha_1.png\|x175px\|link=https://doi.org/10.3390/v13030392]] [[File:article_alpha_2.png\|x175px\|link=https://doi.org/10.3390/v13030392]]<br/><br/>		* <span class="pmbm">Grabowski F</span>, <span class="nopmbm">Preibisch G</span>, <span class="nopmbm">Giziński S</span>, <span class="pmbm">Kochańczyk M</span>, <span class="pmbm">Lipniacki T</span>. '''SARS-CoV-2 Variant of Concern 202012/01 has about twofold replicative advantage and acquires concerning mutations''', ''Viruses'' <u>13</u>(3):392 (2021) [https://doi.org/10.3390/v13030392 CrossRef] [https://doi.org/10.1101/2020.12.28.20248906 medRxiv] \| [https://www.mdpi.com/1999-4915/13/3/392/pdf PDF]<br/>[[File:article_alpha_1.png\|x175px\|link=https://doi.org/10.3390/v13030392]] [[File:article_alpha_2.png\|x175px\|link=https://doi.org/10.3390/v13030392]]<br/><br/>
Line 322:		Line 323:
	===Wyniki===		===Wyniki===
	====Publikacje====		====Publikacje====
			* <span class="nopmbm">Sønstevold L</span>, <span class="pmbm">Czerkies M</span>, <span class="nopmbm">Escobedo-Cousin E</span>, <span class="pmbm">Blonski S</span>, <span class="nopmbm">Vereshchagina E</span>. ''Micromachines'' <u>14</u>(3):532 (2023) [https://dx.doi.org/10.3390/mi14030532 CrossRef]<br/><br/>
	* <span class="author">Czerkies M</span>, <span class="author">Kochańczyk M</span>, <span class="author">Korwek Z</span>, <span class="author">Prus W</span>, <span class="author">Lipniacki T</span>. '''Respiratory syncytial virus protects bystander cells against influenza A virus infection by triggering secretion of type I and type III interferons''', ''J Virol'' (2022) <u>96</u>:22 e01341-22 [https://doi.org/10.1128/jvi.01341-22 CrossRef] [https://doi.org/10.1101/2021.10.11.463877 bioRxiv]<br/>[[File:article_RSV_IAV_crossprotection.png\|450px\|link=https://doi.org/10.1128/jvi.01341-22]]<br/><br/>		* <span class="author">Czerkies M</span>, <span class="author">Kochańczyk M</span>, <span class="author">Korwek Z</span>, <span class="author">Prus W</span>, <span class="author">Lipniacki T</span>. '''Respiratory syncytial virus protects bystander cells against influenza A virus infection by triggering secretion of type I and type III interferons''', ''J Virol'' (2022) <u>96</u>:22 e01341-22 [https://doi.org/10.1128/jvi.01341-22 CrossRef] [https://doi.org/10.1101/2021.10.11.463877 bioRxiv]<br/>[[File:article_RSV_IAV_crossprotection.png\|450px\|link=https://doi.org/10.1128/jvi.01341-22]]<br/><br/>
	* <span class="pmbm">Grabowski F</span>, <span class="nopmbm">Preibisch G</span>, <span class="nopmbm">Giziński S</span>, <span class="pmbm">Kochańczyk M</span>, <span class="pmbm">Lipniacki T</span>. '''SARS-CoV-2 Variant of Concern 202012/01 has about twofold replicative advantage and acquires concerning mutations''', ''Viruses'' <u>13</u>(3):392 (2021) [https://doi.org/10.3390/v13030392 CrossRef] [https://doi.org/10.1101/2020.12.28.20248906 medRxiv] \| [https://www.mdpi.com/1999-4915/13/3/392/pdf PDF]<br/>[[File:article_alpha_1.png\|x175px\|link=https://doi.org/10.3390/v13030392]] [[File:article_alpha_2.png\|x175px\|link=https://doi.org/10.3390/v13030392]]<br/><br/>		* <span class="pmbm">Grabowski F</span>, <span class="nopmbm">Preibisch G</span>, <span class="nopmbm">Giziński S</span>, <span class="pmbm">Kochańczyk M</span>, <span class="pmbm">Lipniacki T</span>. '''SARS-CoV-2 Variant of Concern 202012/01 has about twofold replicative advantage and acquires concerning mutations''', ''Viruses'' <u>13</u>(3):392 (2021) [https://doi.org/10.3390/v13030392 CrossRef] [https://doi.org/10.1101/2020.12.28.20248906 medRxiv] \| [https://www.mdpi.com/1999-4915/13/3/392/pdf PDF]<br/>[[File:article_alpha_1.png\|x175px\|link=https://doi.org/10.3390/v13030392]] [[File:article_alpha_2.png\|x175px\|link=https://doi.org/10.3390/v13030392]]<br/><br/>

Redaktor at 10:07, 27 March 2023

2023-03-27T10:07:24Z

← Older revision		Revision as of 12:07, 27 March 2023
Line 259:		Line 259:
	* Radio TOK FM, three separate conversations ([https://audycje.tokfm.pl/gosc/13792,prof-Tomasz-Lipniacki Polish])		* Radio TOK FM, three separate conversations ([https://audycje.tokfm.pl/gosc/13792,prof-Tomasz-Lipniacki Polish])

	===Public lectures===		====Public lectures====
	* lecture in German Historical Institute Warsaw ([https://www.dhi.waw.pl/pl/wydarzenia/wyklady/detale/prof-tomasz-lipniacki-virale-invasionen-in-geweben-und-gesellschaften])		* lecture in German Historical Institute Warsaw ([https://www.dhi.waw.pl/pl/wydarzenia/wyklady/detale/prof-tomasz-lipniacki-virale-invasionen-in-geweben-und-gesellschaften])

Redaktor at 10:06, 27 March 2023

2023-03-27T10:06:43Z

← Older revision		Revision as of 12:06, 27 March 2023
Line 243:		Line 243:


	===~~In media~~===		===Dissemination===
	====~~Newspaper~~====		====Press====
	* Gazeta Wyborcza, interview, March 2020 ([https://wyborcza.pl/7,75400,25824141,matematyczny-model-rozwoju-epidemii-prof-lipniacki-ograniczenia.html Polish] \| [https://wyborcza.pl/7,173236,25831548,poland-follows-down-the-italian-path-prof-lipniacki-author.html English])		* Gazeta Wyborcza, interview, March 2020 ([https://wyborcza.pl/7,75400,25824141,matematyczny-model-rozwoju-epidemii-prof-lipniacki-ograniczenia.html Polish] \| [https://wyborcza.pl/7,173236,25831548,poland-follows-down-the-italian-path-prof-lipniacki-author.html English])
	* Gazeta Wyborcza, interview, June 2020 ([https://wyborcza.pl/7,75400,25920600,prof-lipniacki-musimy-wiedziec-kto-i-jak-sie-zakaza-aby.html Polish])		* Gazeta Wyborcza, interview, June 2020 ([https://wyborcza.pl/7,75400,25920600,prof-lipniacki-musimy-wiedziec-kto-i-jak-sie-zakaza-aby.html Polish])
Line 258:		Line 258:
	* Polsat News, debate on 4th wave of COVID-19, August 2021 ([https://www.youtube.com/watch?v=rFn_J6nDjo0&t=1554s Polish])		* Polsat News, debate on 4th wave of COVID-19, August 2021 ([https://www.youtube.com/watch?v=rFn_J6nDjo0&t=1554s Polish])
	* Radio TOK FM, three separate conversations ([https://audycje.tokfm.pl/gosc/13792,prof-Tomasz-Lipniacki Polish])		* Radio TOK FM, three separate conversations ([https://audycje.tokfm.pl/gosc/13792,prof-Tomasz-Lipniacki Polish])

			===Public lectures===
			* lecture in German Historical Institute Warsaw ([https://www.dhi.waw.pl/pl/wydarzenia/wyklady/detale/prof-tomasz-lipniacki-virale-invasionen-in-geweben-und-gesellschaften])


Line 343:		Line 346:


	===~~W mediach~~===		===Popularyzacja===
	====~~Gazety~~====		====Prasa====
	* Gazeta Wyborcza, wywiad, marzec 2020 ([https://wyborcza.pl/7,75400,25824141,matematyczny-model-rozwoju-epidemii-prof-lipniacki-ograniczenia.html po polsku], [https://wyborcza.pl/7,173236,25831548,poland-follows-down-the-italian-path-prof-lipniacki-author.html po angielsku])		* Gazeta Wyborcza, wywiad, marzec 2020 ([https://wyborcza.pl/7,75400,25824141,matematyczny-model-rozwoju-epidemii-prof-lipniacki-ograniczenia.html po polsku], [https://wyborcza.pl/7,173236,25831548,poland-follows-down-the-italian-path-prof-lipniacki-author.html po angielsku])
	* Gazeta Wyborcza, wywiad, czerwiec 2020 ([https://wyborcza.pl/7,75400,25920600,prof-lipniacki-musimy-wiedziec-kto-i-jak-sie-zakaza-aby.html po polsku])		* Gazeta Wyborcza, wywiad, czerwiec 2020 ([https://wyborcza.pl/7,75400,25920600,prof-lipniacki-musimy-wiedziec-kto-i-jak-sie-zakaza-aby.html po polsku])
Line 352:		Line 355:
	* Gazeta Wyborcza, wywiad, lipiec 2021 ([https://wyborcza.pl/7,75400,26665472,prof-lipniacki-sars-cov-2-po-raz-kolejny-znaczaco-zmutowal.html po polsku])		* Gazeta Wyborcza, wywiad, lipiec 2021 ([https://wyborcza.pl/7,75400,26665472,prof-lipniacki-sars-cov-2-po-raz-kolejny-znaczaco-zmutowal.html po polsku])

	====Telewizja ~~i radio~~====		====Radio i Telewizja====
	* Polsat News, debata o rozwoju pandemii i roli szczepień, listopad 2020 ([https://www.youtube.com/watch?v=KQIvgg9Oopo&t=391 po polsku])		* Polsat News, debata o rozwoju pandemii i roli szczepień, listopad 2020 ([https://www.youtube.com/watch?v=KQIvgg9Oopo&t=391 po polsku])
	* Polsat News, debata o restrykcjach sylwestrowych, grudzień 2020 ([https://www.youtube.com/watch?v=EvZq4QO9CVw&t=75s po polsku])		* Polsat News, debata o restrykcjach sylwestrowych, grudzień 2020 ([https://www.youtube.com/watch?v=EvZq4QO9CVw&t=75s po polsku])
Line 358:		Line 361:
	* Polsat News, debata o czwartej fali COVID-19, sierpień 2021 ([https://www.youtube.com/watch?v=rFn_J6nDjo0&t=1554s po polsku])		* Polsat News, debata o czwartej fali COVID-19, sierpień 2021 ([https://www.youtube.com/watch?v=rFn_J6nDjo0&t=1554s po polsku])
	* Radio TOK FM, trzy rozmowy ([https://audycje.tokfm.pl/gosc/13792,prof-Tomasz-Lipniacki po polsku])		* Radio TOK FM, trzy rozmowy ([https://audycje.tokfm.pl/gosc/13792,prof-Tomasz-Lipniacki po polsku])

			===Inne===
			* wykład w Niemieckim Instytucie Historycznym w Warszawie ([https://www.dhi.waw.pl/pl/wydarzenia/wyklady/detale/prof-tomasz-lipniacki-virale-invasionen-in-geweben-und-gesellschaften])

Redaktor at 12:03, 22 March 2023

2023-03-22T12:03:45Z

← Older revision		Revision as of 14:03, 22 March 2023
Line 16:		Line 16:

	*''Electrospun conducting hydrogel nanomaterials for neural tissue engineering''.<br/>Foundation for Polish Science ('''FNP'''): '''First Team''', 2019–2022.<br/>PI: Filippo Pierini		*''Electrospun conducting hydrogel nanomaterials for neural tissue engineering''.<br/>Foundation for Polish Science ('''FNP'''): '''First Team''', 2019–2022.<br/>PI: Filippo Pierini

			</div> <!-- CurrentGrants -->
			<div id="PastGrants" class="tab-pane fade" role="tabpanel">

	*''Deciphering biochemical signalling to inform more efficient therapeutic strategies''.<br/>Foundation for Polish Science ('''FNP'''): '''First Team''', 2018–2021<br/>PI: Michał Komorowski		*''Deciphering biochemical signalling to inform more efficient therapeutic strategies''.<br/>Foundation for Polish Science ('''FNP'''): '''First Team''', 2018–2021<br/>PI: Michał Komorowski

	*''Coordination of innate immune response in infected cell population: experiment and mathematical modeling''.<br/>National Science Centre (NCN): Opus 15, 2019–2022.<br/>PI: Tomasz Lipniacki		*''Coordination of innate immune response in infected cell population: experiment and mathematical modeling''.<br/>National Science Centre (NCN): Opus 15, 2019–2022.<br/>PI: Tomasz Lipniacki

	~~</div> <!-- CurrentGrants -->~~
	~~<div id="PastGrants" class="tab-pane fade" role="tabpanel">~~

	*''Development of novel methods for measuring viscosity and interfacial tension of liquids using microfluidic devices''.<br/>National Science Centre (NCN): Preludium 15, 2019–2022.<br/>PI: Damian Zaremba		*''Development of novel methods for measuring viscosity and interfacial tension of liquids using microfluidic devices''.<br/>National Science Centre (NCN): Preludium 15, 2019–2022.<br/>PI: Damian Zaremba